Dendreon Corp (NASDAQ:DNDN) - Page 2

health care

Dendreon Restructuring Aims to Thwart Weak Provenge Sales

Dendreon Corp. (NASDAQ: DNDN) has been down and out, and now the company is going to try a restructuring strategy after earnings, in an effort to save it from the ...
Read Full Story »
Stock Split Image

The Questionable Dendreon Buyout Incentive

Dendreon Corp. (NASDAQ: DNDN) is by almost all measurements nothing short of a total failure of a biotech or biohealth stock. Despite having a solid prostate cancer treatment in Provenge, ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: CenturyLink, Dendreon, Gap, ING, VMWare and More

It is an August Friday, and there are a surprising number of research calls before the week ahead, which is usually the slowest week of the year other than the ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Fade Further to Close

August 9, 2013: U.S. equity markets opened lower this morning and bounced around below the break-even line most of the day. The day’s biggest economic news came from China, where ...
Read Full Story »
Food and Drug Administration logo

Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo

Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer through to the market. Even a direct to consumer advertising campaign has so ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Mixed, Close Higher

U.S. equity markets opened mixed this morning and failed to find a direction driver throughout the trading day. In Europe, Germany reported a stronger-than-expected trade surplus, while the U.K.’s trade ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Dean Foods, Dendreon, Mylan and More

Investors frequently see analyst upgrades and Buy ratings from Wall Street research calls, but they often do not get to see the so-called Sell ratings. 24/7 Wall St. reviews many ...
Read Full Story »
biotech

Dendreon Shows Poor Provenge Sales, Implosion Risk Rising

Dendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ARO, MO, ADM, ATML, CL, CVRR, DNDN, IGT, IP, NKE, LULU, LOW, LSI, OKS, SNDK, TEF, TPH, YUM, CQP, LNG)

These are some of this Tuesday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Aeropostale Inc. (NYSE: ARO) named Bear of the Day as expensive even ...
Read Full Story »
Bull and Bear

The Top 20 Must-Watch Earnings for the Week Ahead

The week ahead is going to have many key earnings reports. Retail is heavily represented, while technology and banking giants are non-existent. Some of these are stocks which can move ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (CTL, SCHW, CL, DELL, DNDN, ETFC, JCP, LEAP, MAS, NVDA, OII, PLCM, PBH, PG, LMT, RAX, AMTD, VZ)

These are some of this Thursday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. CenturyLink Inc. (NYSE: CTL) cut to Neutral at J.P. Morgan, cut to ...
Read Full Story »
Bull and Bear figures

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.09%, the Nasdaq down 0.57% and the S&P 500 down 0.33%. Today's winners include a smartphone manufacturer ...
Read Full Story »
biotech

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

Cancer ranks on the list of global killers as number two. Over the years, great strides have been made not only in cancer treatment but in survival rates for many different ...
Read Full Story »
biotech

Can Dendreon’s Stock Really Double Again?

Dendreon Corp. (NASDAQ: DNDN) is seeing shares surge higher on Friday on an analyst upgrade. The move higher is part because Dendreon has a long history of boom and bust ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ADTN, AIG, AAPL, CPB, CTRN, DNDN, DPS, EA, GIS, JCP, MMM, NOK, PM, RIMM, THC, VIAB, WYNN)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research firms this Friday. ADTRAN Inc. (NASDAQ: ADTN) maintained Underperform but named Bear of the ...
Read Full Story »